Parenteral or enteral arginine supplementation safety and efficacy

Martin D. Rosenthal, Phillip W. Carrott, Jayshil Patel, Laszlo Kiraly, Robert Martindale

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Arginine supplementation has the potential to improve the health of patients. Its use in hospitalized patients has been a controversial topic in the nutrition literature, especially concerning supplementation of septic patients. In this article, we review the relevant literature both for and against the use of arginine in critically ill, surgical, and hospitalized patients. The effect of critical illness on arginine metabolism is reviewed, as is its use in septic and critically ill patients. Although mounting evidence supports immunonutrition, there are only a few studies that suggest that this is safe in patients with severe sepsis. The use of arginine has been shown to benefit a variety of critically ill patients. It should be considered for inclusion in combinations of immunonutrients or commercial formulations for groups in whom its benefit has been reported consistently, such as those who have suffered trauma and those in acute surgical settings. The aims of this review are to discuss the role of arginine in health, the controversy surrounding arginine supplementation of septic patients, and the use of arginine in critically ill patients.

Original languageEnglish (US)
Pages (from-to)2594S-2600S
JournalJournal of Nutrition
Volume146
Issue number12
DOIs
StatePublished - Dec 1 2016

Fingerprint

Small Intestine
Arginine
Safety
Critical Illness
Health
Sepsis
Wounds and Injuries

Keywords

  • Arginine supplementation
  • Critical care
  • Immunonutrition
  • Sepsis
  • Surgery

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Nutrition and Dietetics

Cite this

Parenteral or enteral arginine supplementation safety and efficacy. / Rosenthal, Martin D.; Carrott, Phillip W.; Patel, Jayshil; Kiraly, Laszlo; Martindale, Robert.

In: Journal of Nutrition, Vol. 146, No. 12, 01.12.2016, p. 2594S-2600S.

Research output: Contribution to journalArticle

Rosenthal, MD, Carrott, PW, Patel, J, Kiraly, L & Martindale, R 2016, 'Parenteral or enteral arginine supplementation safety and efficacy', Journal of Nutrition, vol. 146, no. 12, pp. 2594S-2600S. https://doi.org/10.3945/jn.115.228544
Rosenthal, Martin D. ; Carrott, Phillip W. ; Patel, Jayshil ; Kiraly, Laszlo ; Martindale, Robert. / Parenteral or enteral arginine supplementation safety and efficacy. In: Journal of Nutrition. 2016 ; Vol. 146, No. 12. pp. 2594S-2600S.
@article{207adc56d0aa446cb2d9dcbe6daa1676,
title = "Parenteral or enteral arginine supplementation safety and efficacy",
abstract = "Arginine supplementation has the potential to improve the health of patients. Its use in hospitalized patients has been a controversial topic in the nutrition literature, especially concerning supplementation of septic patients. In this article, we review the relevant literature both for and against the use of arginine in critically ill, surgical, and hospitalized patients. The effect of critical illness on arginine metabolism is reviewed, as is its use in septic and critically ill patients. Although mounting evidence supports immunonutrition, there are only a few studies that suggest that this is safe in patients with severe sepsis. The use of arginine has been shown to benefit a variety of critically ill patients. It should be considered for inclusion in combinations of immunonutrients or commercial formulations for groups in whom its benefit has been reported consistently, such as those who have suffered trauma and those in acute surgical settings. The aims of this review are to discuss the role of arginine in health, the controversy surrounding arginine supplementation of septic patients, and the use of arginine in critically ill patients.",
keywords = "Arginine supplementation, Critical care, Immunonutrition, Sepsis, Surgery",
author = "Rosenthal, {Martin D.} and Carrott, {Phillip W.} and Jayshil Patel and Laszlo Kiraly and Robert Martindale",
year = "2016",
month = "12",
day = "1",
doi = "10.3945/jn.115.228544",
language = "English (US)",
volume = "146",
pages = "2594S--2600S",
journal = "Journal of Nutrition",
issn = "0022-3166",
publisher = "American Society for Nutrition",
number = "12",

}

TY - JOUR

T1 - Parenteral or enteral arginine supplementation safety and efficacy

AU - Rosenthal, Martin D.

AU - Carrott, Phillip W.

AU - Patel, Jayshil

AU - Kiraly, Laszlo

AU - Martindale, Robert

PY - 2016/12/1

Y1 - 2016/12/1

N2 - Arginine supplementation has the potential to improve the health of patients. Its use in hospitalized patients has been a controversial topic in the nutrition literature, especially concerning supplementation of septic patients. In this article, we review the relevant literature both for and against the use of arginine in critically ill, surgical, and hospitalized patients. The effect of critical illness on arginine metabolism is reviewed, as is its use in septic and critically ill patients. Although mounting evidence supports immunonutrition, there are only a few studies that suggest that this is safe in patients with severe sepsis. The use of arginine has been shown to benefit a variety of critically ill patients. It should be considered for inclusion in combinations of immunonutrients or commercial formulations for groups in whom its benefit has been reported consistently, such as those who have suffered trauma and those in acute surgical settings. The aims of this review are to discuss the role of arginine in health, the controversy surrounding arginine supplementation of septic patients, and the use of arginine in critically ill patients.

AB - Arginine supplementation has the potential to improve the health of patients. Its use in hospitalized patients has been a controversial topic in the nutrition literature, especially concerning supplementation of septic patients. In this article, we review the relevant literature both for and against the use of arginine in critically ill, surgical, and hospitalized patients. The effect of critical illness on arginine metabolism is reviewed, as is its use in septic and critically ill patients. Although mounting evidence supports immunonutrition, there are only a few studies that suggest that this is safe in patients with severe sepsis. The use of arginine has been shown to benefit a variety of critically ill patients. It should be considered for inclusion in combinations of immunonutrients or commercial formulations for groups in whom its benefit has been reported consistently, such as those who have suffered trauma and those in acute surgical settings. The aims of this review are to discuss the role of arginine in health, the controversy surrounding arginine supplementation of septic patients, and the use of arginine in critically ill patients.

KW - Arginine supplementation

KW - Critical care

KW - Immunonutrition

KW - Sepsis

KW - Surgery

UR - http://www.scopus.com/inward/record.url?scp=85007008214&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85007008214&partnerID=8YFLogxK

U2 - 10.3945/jn.115.228544

DO - 10.3945/jn.115.228544

M3 - Article

VL - 146

SP - 2594S-2600S

JO - Journal of Nutrition

JF - Journal of Nutrition

SN - 0022-3166

IS - 12

ER -